Ionis Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2007 | — | $59.6M | $138.6M |
| Dec 2008 | — | $147.4M | $224.0M |
| Jun 2009 | — | — | $215.8M |
| Sep 2009 | — | — | $149.3M |
| Dec 2009 | $11.5M | $291.7M | $105.3M |
| Mar 2010 | — | — | $98.6M |
| Jun 2010 | $5.6M | $262.2M | $46.0M |
| Sep 2010 | $4.3M | $253.7M | $100.1M |
| Dec 2010 | $148.8M | $244.5M | $70.1M |
| Mar 2011 | $4.9M | $227.7M | $86.2M |
| Jun 2011 | $5.5M | $212.2M | $85.0M |
| Sep 2011 | $4.7M | $186.8M | $55.3M |
| Dec 2011 | $145.6M | $171.4M | $65.5M |
| Mar 2012 | — | $150.9M | $56.4M |
| Jun 2012 | — | $154.3M | $85.6M |
| Sep 2012 | — | $170.3M | $84.6M |
| Dec 2012 | — | $182.8M | $124.5M |
| Mar 2013 | — | $201.1M | $107.7M |
| Jun 2013 | — | $401.1M | $296.5M |
| Sep 2013 | — | $401.4M | $256.4M |
| Dec 2013 | — | $378.4M | $160.0M |
| Mar 2014 | — | $374.1M | $161.8M |
| Jun 2014 | — | $366.9M | $94.1M |
| Sep 2014 | — | $344.8M | $73.2M |
| Dec 2014 | — | $257.8M | $143.0M |
| Mar 2015 | — | $275.9M | $148.3M |
| Jun 2015 | — | $300.3M | $119.5M |
| Sep 2015 | — | $245.4M | $126.6M |
| Dec 2015 | — | $200.8M | $128.8M |
| Mar 2016 | — | $158.2M | $93.3M |
| Jun 2016 | — | $111.2M | $112.5M |
| Sep 2016 | — | $139.6M | $84.3M |
| Dec 2016 | — | $99.6M | $84.7M |
| Mar 2017 | — | $201.8M | $114.2M |
| Jun 2017 | — | $215.6M | $133.0M |
| Sep 2017 | — | $308.0M | $159.2M |
| Dec 2017 | — | $281.0M | $129.6M |
| Mar 2018 | — | $301.4M | $227.5M |
| Jun 2018 | — | $696.3M | $805.5M |
| Sep 2018 | — | $710.6M | $479.9M |
| Dec 2018 | — | $1.05B | $278.8M |
| Mar 2019 | — | $1.21B | $375.8M |
| Jun 2019 | — | $1.27B | $272.5M |
| Sep 2019 | — | $1.34B | $247.9M |
| Dec 2019 | $785.5M | $1.47B | $683.3M |
| Mar 2020 | — | $1.36B | $486.2M |
| Jun 2020 | — | $1.38B | $530.2M |
| Sep 2020 | — | $1.38B | $633.1M |
| Dec 2020 | $539.1M | $743.3M | $397.7M |
| Mar 2021 | — | $680.6M | $414.2M |
| Jun 2021 | — | $582.7M | $565.1M |
| Sep 2021 | — | $530.5M | $633.0M |
| Dec 2021 | — | $771.7M | $869.2M |
| Mar 2022 | — | $709.6M | $542.5M |
| Jun 2022 | — | $624.7M | $521.9M |
| Sep 2022 | — | $594.4M | $315.0M |
| Dec 2022 | $1.18B | $572.9M | $276.5M |
| Mar 2023 | — | $486.6M | $309.0M |
| Jun 2023 | — | $428.3M | $424.8M |
| Sep 2023 | — | $315.5M | $352.1M |
| Dec 2023 | $1.24B | $386.7M | $399.3M |
| Mar 2024 | — | $296.5M | $348.9M |
| Jun 2024 | — | $263.7M | $294.0M |
| Sep 2024 | — | $662.5M | $334.6M |
| Dec 2024 | $1.20B | $588.4M | $242.1M |
| Mar 2025 | — | $475.7M | $264.2M |
| Jun 2025 | — | $631.7M | $297.3M |
| Sep 2025 | — | $618.0M | $338.3M |
| Dec 2025 | $1.33B | $489.1M | $372.3M |
| Mar 2026 | — | $491.4M | $173.4M |
| Jun 2026 | — | $439.7M | $350.1M |